CVE-2026-34324

CVE-2026-34324 is a medium-severity vulnerability in Oracle Life Sciences Inform with a CVSS 3.x base score of 6.5. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-284.

Key facts

Description

Vulnerability in the Oracle Life Sciences InForm product of Oracle Life Science Applications (component: App Server). Supported versions that are affected are 7.0.1.0 and 7.0.1.1. Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Life Sciences InForm. Successful attacks of this vulnerability can result in unauthorized update, insert or delete access to some of Oracle Life Sciences InForm accessible data as well as unauthorized read access to a subset of Oracle Life Sciences InForm accessible data. CVSS 3.1 Base Score 6.5 (Confidentiality and Integrity impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:N).

Frequently asked questions

What is CVE-2026-34324?
Vulnerability in the Oracle Life Sciences InForm product of Oracle Life Science Applications (component: App Server). Supported versions that are affected are 7.0.1.0 and 7.0.1.1. Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Life Sciences InForm. Successful attacks of this vulnerability can result in unauthorized update, insert or delete access to some of Oracle Life Sciences InForm accessible data as well as unauthorized read access to a subset of Oracle Life Sciences InForm accessible data. CVSS 3.1 Base Score 6.5 (Confidentiality and Integrity impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:N).
How severe is CVE-2026-34324?
CVE-2026-34324 has a CVSS 3.x base score of 6.5, rated medium severity. It is exploitable over network with low attack complexity, requires no privileges and no user interaction. Impact on confidentiality is low, integrity low, and availability none.
Is CVE-2026-34324 being actively exploited?
It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (10th percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2026-34324?
CVE-2026-34324 primarily affects Oracle Life Sciences Inform. In total, 2 product configurations (CPEs) are listed as vulnerable; see the affected-products list for the exact versions.
How do I fix CVE-2026-34324?
Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.
Does CVE-2026-34324 have an EU (EUVD) identifier?
Yes. CVE-2026-34324 is tracked in the ENISA EU Vulnerability Database (EUVD) as EUVD-2026-24428.
When was CVE-2026-34324 published?
CVE-2026-34324 was published on 2026-04-21 and last updated on 2026-06-17.

References

Affected products (2)

More vulnerabilities in Oracle Life Sciences Inform

All CVEs affecting Oracle Life Sciences Inform →

Other CWE-284 (Improper Access Control) vulnerabilities

Browse all CWE-284 (Improper Access Control) vulnerabilities →